Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
about
Mechanism of Action and Applications of Interleukin 24 in ImmunotherapyTargeting Mcl-1 for the therapy of cancerDeveloping an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicTherapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimeticThe p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cellsEradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaThe non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.The development of MDA-7/IL-24 as a cancer therapeuticRecombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivo.A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapyA serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approachEnhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineBiomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomamda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.MDA-7/IL-24: multifunctional cancer killing cytokineConstruction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targetingMDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceHistone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesTAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells.Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction.Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cellsClinical applications of mouse models for breast cancer engaging HER2/neu.mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis.Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis.MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.IL-24 sensitizes tumor cells to TLR3-mediated apoptosisThe novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells.
P2860
Q26748450-792E14D7-5660-4390-8210-7A91A126E6E2Q27011870-2D6A5295-BA8B-4A8A-A178-CCC2AA9ACB0AQ27694606-3E761489-3159-4A3E-B4D7-519FC90E5083Q30300019-112C6804-1046-4B9A-B57D-D51E7861D839Q33523814-F0FFFAF9-FD81-476B-BD73-16AF10AED7B5Q33613377-0068CC12-923C-4646-BE6C-8CC768B02176Q33730689-717C7EF6-370F-4BED-BE79-5966A4AB8D16Q33870560-2B45E730-C555-4CEC-A9ED-61131EE2B644Q33930115-6AC24BF0-7C61-44F7-B9D0-D17E345B8BDEQ33955558-71D97BC8-B658-4A5A-9DC9-6C80F4607042Q34041932-1028A7DB-B62E-4F2E-866C-D4926C16ED46Q34073228-C1B5C315-062B-40DD-B98B-D1C9A5902935Q34163896-263F21D1-3B54-4152-9E97-BFFAD235B8E6Q34238776-4165AC0B-AA5E-4380-9136-84DD5A6B5648Q34341900-5A6941E0-F5C3-42EE-A065-0C7974B1EB81Q34701049-5F04D976-15AA-48B4-B749-DBED87A1AB4CQ34946787-DB9C9778-364D-40D9-886A-74E25599341DQ35095082-BF24F927-8132-4DDA-98C9-47B1502C6658Q35101122-563B228C-FE7F-45F0-BE08-E14D2C568D42Q35142325-457A3A07-E204-4398-BC47-06C80ED0E239Q35186312-519A5279-D433-4AA6-ADDA-78F676BE059FQ35189796-2979AE0B-A1B6-4391-AD1F-5109E90FA3C6Q35209685-4F7D1A2C-4104-4FBA-9335-9DD75B60F983Q35234354-6DD5425B-290C-4D2E-AA57-2D698F45DFCBQ35587172-D112A945-47E8-49A0-BB7A-55535F1E1575Q36248193-0767D865-74B5-44A7-B83D-9C8F49961948Q36249337-C51A171D-C73E-4268-9D35-E361059DE413Q36545635-AB423E51-6C36-46F8-A31E-DBFA6EBD2281Q36545638-4D59645B-0F51-495E-85FA-EA18A34954F6Q37027060-8D5C6BBF-35E3-4413-B8A3-030F63515E4DQ37149641-3F65FAAF-3B78-42A7-A56E-E307301CF704Q37392899-25752B6B-8354-4E5A-8E31-10CA25E4756FQ37561261-B0EF46E0-BB40-4612-AA59-51CE83582AD6Q37586906-5B15FD52-2DC8-418B-8E33-F53A021BE298Q37607675-F541B4D8-D73D-4D2C-BCAE-3C819E7B9834Q38726742-C95821DE-871B-4D05-BAAA-EDC0A2A9C186Q38868901-E8365654-7847-4817-B7EF-A96FC6D69834Q38955183-24469941-B7E7-43C7-87DC-DA0579A43ACDQ39187167-BFB9D3BC-7969-4854-A628-B4008FAD9455Q39515645-FC73DD56-0D88-4641-A84D-6C99B16058EA
P2860
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@ast
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@en
type
label
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@ast
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@en
prefLabel
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@ast
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@en
P2093
P2860
P356
P1476
Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.
@en
P2093
Devanand Sarkar
Irina V Lebedeva
Moira Sauane
Pankaj Gupta
Paul B Fisher
Zao-Zhong Su
P2860
P304
P356
10.1073/PNAS.0804089105
P407
P50
P577
2008-07-03T00:00:00Z